Division of Thoracic Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland.
Pulmonary & Critical Care Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
J Heart Lung Transplant. 2023 Jun;42(6):693-696. doi: 10.1016/j.healun.2023.03.001. Epub 2023 Mar 8.
Thoracoabdominal normothermic regional perfusion (TA-NRP) has recently begun being utilized in the United States for recovery of cardiothoracic allografts from some donors after circulatory death (DCD), but data on lungs recovered in this method is limited to case reports. We conducted a national retrospective review of lung transplants from DCD donors recovered using TA-NRP. Of the 434 total DCD lung transplants performed between January 2020 and March 2022, 17 were recovered using TA-NRP. Compared to direct recovery DCD transplants, recipients of TA-NRP DCD transplants had lower likelihood of ventilation >48 hours (23.5% vs 51.3%, p = 0.027) and similar likelihood of predischarge acute rejection, requirement for extracorporeal membrane oxygenation at 72 hours, hospital lengths of stay, and survival at 30, 60, and 90 days post-transplant. These early data suggest that DCD lung recovery using TA-NRP might be a safe way to further expand the donor pool and warrant further study.
胸腹腔常温区域灌注(TA-NRP)最近开始在美国用于从一些循环死亡(DCD)供体中回收心肺供体,但关于用这种方法回收的肺的数据仅限于病例报告。我们对使用 TA-NRP 从 DCD 供体中回收的肺移植进行了全国性回顾性研究。在 2020 年 1 月至 2022 年 3 月期间进行的 434 例 DCD 肺移植中,有 17 例使用 TA-NRP 进行了回收。与直接回收 DCD 移植相比,接受 TA-NRP DCD 移植的患者通气时间>48 小时的可能性较低(23.5%比 51.3%,p=0.027),但急性排斥反应的发生率、72 小时需要体外膜氧合的可能性、住院时间和移植后 30、60 和 90 天的生存率相似。这些早期数据表明,使用 TA-NRP 从 DCD 中回收肺可能是进一步扩大供体库的安全方法,值得进一步研究。